West Pharmaceutical Services, Inc.SEC Filings
|
|
All SEC filings by West Pharmaceutical Services, Inc. (WST) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 23, 2026 | |
| 10-Q | Quarterly report | View Diff | Apr 23, 2026 | |
| 10-K | Annual report | View Diff | Feb 17, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 23, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 24, 2025 | |
| 10-Q | Quarterly report | View Diff | Apr 24, 2025 | |
| ARS | Annual report to shareholders | Mar 21, 2025 | ||
| 10-K | Annual report | View Diff | Feb 18, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 24, 2024 | |
| 10-Q | Quarterly report | View Diff | Jul 25, 2024 |
Events
| 8-K | West Reports Second-Quarter 2026 Results | Jul 23, 2026 | ||
| 8-K | Current report | Jul 14, 2026 | ||
| 8-K | Current report | Jun 1, 2026 | ||
| 8-K/A | 1.05 | May 20, 2026 | ||
| 8-K | 1.05 | May 11, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | May 5, 2026 | ||
| 8-K | West Reports First-Quarter 2026 Results | Apr 23, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Mar 9, 2026 | ||
| 8-K | West Reports Fourth-Quarter and Full-Year 2025 Results | Feb 12, 2026 | ||
| 8-K | West Reports Third-Quarter 2025 Results | Oct 23, 2025 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Aug 20, 2025 | ||
| S-8 POS | Registration of securities for employees (post-effective amendment) | Oct 23, 2024 | ||
| S-8 POS | Registration of securities for employees (post-effective amendment) | Oct 23, 2024 | ||
| S-8 | Registration of securities for employees | May 3, 2016 | ||
| SC TO-I/A | Issuer tender offer statement | Jun 6, 2012 | ||
| SC TO-I/A | Issuer tender offer statement | Jun 4, 2012 | ||
| SC TO-C | Information about tender offer | May 8, 2012 | ||
| SC TO-I | Issuer tender offer statement | May 8, 2012 | ||
| S-8 | Registration of securities for employees | May 12, 2011 | ||
| S-8 | Registration of securities for employees | Dec 29, 2010 |
Proxies
| DEFA14A | Annual Meeting | Mar 12, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Mar 12, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Mar 21, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 21, 2025 | |
| PRE 14A | Preliminary proxy | View Diff | Mar 11, 2025 | |
| PX14A6G | Letter to shareholders | Mar 19, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 13, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 13, 2024 | |
| PRE 14A | Preliminary proxy | Mar 1, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 15, 2023 |
Other
| SD | Conflict minerals disclosure | May 13, 2026 | ||
| SD | Conflict minerals disclosure | May 21, 2025 | ||
| SD | Conflict minerals disclosure | May 22, 2024 | ||
| SD | Conflict minerals disclosure | May 25, 2023 | ||
| SD | Conflict minerals disclosure | May 26, 2022 | ||
| SD | Conflict minerals disclosure | May 28, 2021 | ||
| SD | Conflict minerals disclosure | May 28, 2020 | ||
| SD | Conflict minerals disclosure | May 30, 2019 | ||
| CT ORDER | Confidential treatment order | Aug 21, 2018 | ||
| SD | Conflict minerals disclosure | May 25, 2018 |
Ownership
| 4 | Haugen Janet Brutschea | Oct 2, 2026 | ||
| 4 | Favorite Annette F | Sep 15, 2026 | ||
| 4 | Favorite Annette F | Sep 10, 2026 | ||
| 4 | Lagarde Michel | Sep 10, 2026 | ||
| 3 | Lagarde Michel | Sep 10, 2026 | ||
| 4 | Mcmahon Robert W. | Aug 12, 2026 | ||
| SC 13G | Fmr Llc Acquires 5.0% Stake in West Pharmaceutical Services Inc | Aug 6, 2026 | ||
| 4 | Haugen Janet Brutschea | Jul 1, 2026 | ||
| 4 | Shane Alden Campbell | May 14, 2026 | ||
| 144 | Notice of proposed sale of securities | May 7, 2026 |